Immunological and prognostic analysis of PSENEN in low-grade gliomas: An immune infiltration-related prognostic biomarker.

Chen, Kaijie; Liang, Beibei; Ma, Wenhao; Wan, Guoqing; Chen, Bing; Lu, Changlian; Luo, Yuzhou; Gu, Xuefeng

Chen, Kaijie; Liang, Beibei; Ma, Wenhao; Wan, Guoqing; Chen, Bing; Lu, Changlian; Luo, Yuzhou; Gu, Xuefeng.

Afiliação

Chen K; Shanghai Key Laboratory of Molecular Imaging, Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Liang B; School of Health Science and Engineering, The University of Shanghai for Science and Technology, Shanghai, China.
Ma W; Shanghai Key Laboratory of Molecular Imaging, Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Wan G; School of Health Science and Engineering, The University of Shanghai for Science and Technology, Shanghai, China.
Chen B; School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Lu C; Shanghai Key Laboratory of Molecular Imaging, Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Luo Y; School of Health Science and Engineering, The University of Shanghai for Science and Technology, Shanghai, China.
Gu X; Shanghai Key Laboratory of Molecular Imaging, Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, China.

Front Mol Neurosci ; 15: 933855, 2022.

Article em En | MEDLINE | ID: mdl-35966015

Palavras-chave

PEN2 (PSENEN); immune infiltration; low-grade glioma; macrophage M2; metformin; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Mol Neurosci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google